(Q36401520)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

0 references

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

L Landuzzi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

K Boggio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

G Nicoletti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

E Di Carlo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

I Rossi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

C De Giovanni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

P Bouchard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

S Wolf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

A Modesti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

P Musiani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

G Forni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

language of work or name

English

0 references

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

Journal of Experimental Medicine

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

589-596

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

Oncogenic proteins as tumor antigens

13 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Effect of interleukin 12 on tumor induction by 3-methylcholanthrene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Human Mig chemokine: biochemical and functional characterization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Induction of angiogenesis during the transition from hyperplasia to neoplasia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Antitumor Efficacy of Adenocarcinoma Cells Engineered to Produce Interleukin 12 (IL-12) or Other Cytokines Compared With Exogenous IL-12

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Activated neu induces rapid tumor progression

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Inhibition of angiogenesis in vivo by interleukin 12.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

The advent of the "unpatients'.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212479

CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes

21 September 2018

1 reference

12 December 2020

Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12

1 reference

12 December 2020

Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells

1 reference

12 December 2020

Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10

1 reference

12 December 2020

Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo

1 reference

12 December 2020

Halting angiogenesis suppresses carcinoma cell invasion

1 reference

12 December 2020

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

12 December 2020

Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity

1 reference

12 December 2020

Early and multifocal tumors in breast, salivary, Harderian and epididymal tissues developed in MMTY-Neu transgenic mice

1 reference

12 December 2020

Identifiers

DOI

10.1084/JEM.188.3.589

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

PubMed publication ID

9687535

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9687535%20AND%20SRC:MED&resulttype=core&format=json